TG THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$61.18
+5.34%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+14.1%
3 months
+32.5%
6 months
+80.7%
1 year
+79.8%
Year to date
+105.2%
52-week range
$26.94 – $61.18
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$9.36B
P/E
21.2
P/B
15.5
P/S
11.7
Revenue
$799.54M
Net income
$441.49M
Diluted EPS
2.75
Gross margin
82.40%
Net margin
55.20%
Return on equity
72.30%
Total debt
$752.53M
Cash
$483.94M
Free cash flow
$17.39M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $240.34M | $7.78M | 82.90% | 3.20% | $38.97M |
| Mar 31, 2026 | $204.92M | $19.78M | 83.60% | 9.70% | -$17.95M |
| Dec 31, 2025 | $192.57M | $23.04M | 80.20% | 12.00% | $19.59M |
| Sep 30, 2025 | $161.71M | $390.9M | 82.60% | 241.70% | -$23.23M |
| Jun 30, 2025 | $141.15M | $28.19M | 86.60% | 20.00% | $7.39M |
| Mar 31, 2025 | $120.86M | $5.06M | 87.10% | 4.20% | -$28.74M |
| Dec 31, 2024 | $108.19M | $23.33M | 85.80% | 21.60% | -$25.66M |
| Sep 30, 2024 | $83.88M | $3.88M | 88.90% | 4.60% | -$12.23M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent TGTX news
All market newsNo ticker-linked stories are in the current archive.